1. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation
   Simon McArthur et al, 2015, The Journal of Immunology CrossRef
2. A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids
   Yang Yu et al, 2021, Frontiers in Oncology CrossRef
3. Ferroptosis induction via targeting metabolic alterations in head and neck cancer
   Jaewang Lee et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
4. Retracted: Microrna‐139‐5p inhibits epithelial‐mesenchymal transition and fibrosis in post‐menopausal women with interstitial cystitis by targeting LPAR4 via the PI3K/Akt signaling pathway
   Chen Jiang et al, 2018, Journal of Cellular Biochemistry CrossRef
5. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
   Luiz Henrique Medeiros Geraldo et al, 2021, Signal Transduction and Targeted Therapy CrossRef
6. Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
   Yu-Hsuan Lin et al, 2021, Cells CrossRef
7. Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
   Ingvild J Brusevold et al, 2014, BMC Cancer CrossRef
8. Lysophospholipid Signalling and the Tumour Microenvironment
   Wayne Ng et al, 2021, Tumor Microenvironment CrossRef
9. The role of lysophosphatidic acid in the physiology and pathology of the skin
   Li Lei et al, 2019, Life Sciences CrossRef
10. Towards selective lysophospholipid GPCR modulators
    Julia K. Archbold et al, 2014, Trends in Pharmacological Sciences CrossRef
11. Whole exome sequencing identifies lncRNAGAS8-AS1andLPAR4as novel papillary thyroid carcinoma driver alternations
    Wenting Pan et al, 2016, Human Molecular Genetics CrossRef
12. Elucidating the binding mechanism of LPA species and analogs in an LPA4 receptor homology model
    Huiqun Wang et al, 2022, Journal of Molecular Graphics and Modelling CrossRef
13. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
    Yi Yu et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
14. Epigenetic Identification of ADCY4 as a Biomarker for Breast Cancer: an Integrated Analysis of Adenylate Cyclases
    Yu Fan et al, 2019, Epigenomics CrossRef
15. Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy
    Xiaoyun Tang et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
16. Targeting lipid mediators in cancer biology
    Megan L. Sulciner et al, 2018, Cancer and Metastasis Reviews CrossRef
17. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer
    Ming Quan et al, 2017, Tumor Biology CrossRef
18. Regulation of tumor cell – Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis
    Gabor J. Tigyi et al, 2019, Advances in Biological Regulation CrossRef
19. Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients
    Mariati Abdul Rahman et al, 2020, PeerJ CrossRef
20. GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer
    Avaniyapuram Kannan Murugan et al, 2019, Oncotarget CrossRef
21. Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
    Yan Xu, 2019, Cancers CrossRef